CAS: 133991-63-6
Loteprednol Impurity 1
CAS:133991-63-6
Formula:
C23H30O7
Color and Shape:
White To Off-White Solid
Molecular weight:
418.49
Ref: 4Z-L-395
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
(11b,17a)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic Acid
CAS:133991-63-6
Stability Hygroscopic Applications (11β,17α)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic acid is a derivative of Loteprednol Etabonate (L471400) which is an …
Formula:
C23H30O7
Color and Shape:
White To Off-White
Molecular weight:
418.48
Ref: TR-E890570
250mg | 313.00 € | ||
2500mg | 1,993.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
(11β,17alphalpha)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic acid-d5
Controlled ProductCAS:133991-63-6
Formula:
C23H25D5O7
Color and Shape:
Neat
Molecular weight:
423.51
Ref: TR-E890572
100mg | 2,137.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(11Beta,17Alpha)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic Acid-d3
Controlled ProductCAS:133991-63-6
Formula:
C23H27D3O7
Color and Shape:
Neat
Molecular weight:
421.5
Ref: TR-E890571
5mg | 168.00 € | ||
10mg | 268.00 € | ||
25mg | 612.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(11β,17α)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic acid
CAS:133991-63-6
Please enquire for more information about (11Beta,17Alpha)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic acid including the price, delivery time and more …
Formula:
C23H30O7
Purity:
Min. 95%
Molecular weight:
418.5 g/mol
Ref: 3D-IFA99163
1g | Discontinued | Request information | |
10mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |